Fonon Technologies Presented BTS(TM) Additive Manufacturing Concept at 2025 TechConnect World Innovation Conference
Bulk-to-Shape™ (BTS) Transformational Technology by Fonon Technologies is the result of proprietary intellectual property with the latest developments in 3D metal printing, reinforced by a family of patents from the Lawrence Livermore National Security Lab. This technology is developed to cut downtime and reduce costs by effectively reproducing the needed components out of recycled raw material. First breaking down the material into a consistent powder, a BTS-powered system then 3D-prints the component at precise specifications, achieving tight tolerances.
Last week, Fonon Technologies demonstrated its innovative concept at the 2025 TechConnect World Innovation Conference in Austin, Texas, at JW Marriott Austin.
'It was an exciting opportunity to talk about Bulk-to-Shape™ at the 2025 TechConnect and we extend our sincere gratitude for this invitation,' said Bryan Lee, Vice President of Fonon Technologies. 'We led a discussion on how this innovation can simplify prototyping and metal part production in remote or expeditionary environments.'
The 2025 TechConnect World Innovation Conference connects applied research and early-stage innovations from universities, labs, and startups with industry end users and scouts. The event includes the annual SBIR/STTR Innovation Conference; more than 35 technical symposia; and the Nanotech Conference, the world's largest and longest running nanotechnology event. Among the sponsors and partners were Ames Laboratory, Chevron, Lockheed Martin, United States Army, DARPA, Department of Energy, NASA, Department of the Navy, and other agencies, companies, and universities.
About Fonon Technologies
Fonon Technologies is a diversified industrial laser equipment provider serving government organizations, all branches of the U.S. military, and defense contractors. Led by a team with deep expertise in military and naval operations, the company tackles the challenges of defense maintenance, repair, overhaul and protection with advanced laser solutions. For more information, visit https://www.fonon.us.
Media Contact:
Elizaveta Smirnova
Fonon Technologies
[email protected]
407.804.1000
SOURCE: Fonon Technologies
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
27 minutes ago
- Fox News
Should Josh Allen be ranked over Patrick Mahomes despite 0–4 playoff record against him? Fox News Video
All times eastern Special Report with Bret Baier Fox Business in Depth: Red, White and Blue Collar/Dagen McDowell Fox Business In Depth: "Reenergizing America" FOX News Radio Live Channel Coverage WATCH LIVE: President Trump expected to sign "Big Beautiful Bill" at Fourth of July picnic
Fox News
27 minutes ago
- Fox News
Will a team be hitting the jackpot with Dame Lilliard? Fox News Video
All times eastern Special Report with Bret Baier Fox Business in Depth: Red, White and Blue Collar/Dagen McDowell Fox Business In Depth: "Reenergizing America" FOX News Radio Live Channel Coverage WATCH LIVE: President Trump expected to sign "Big Beautiful Bill" at Fourth of July picnic
Yahoo
31 minutes ago
- Yahoo
The Lovesac Company's (NASDAQ:LOVE) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Lovesac (NASDAQ:LOVE) has had a great run on the share market with its stock up by a significant 34% over the last three months. But the company's key financial indicators appear to be differing across the board and that makes us question whether or not the company's current share price momentum can be maintained. Specifically, we decided to study Lovesac's ROE in this article. Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Lovesac is: 6.8% = US$14m ÷ US$201m (Based on the trailing twelve months to May 2025). The 'return' refers to a company's earnings over the last year. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.07. View our latest analysis for Lovesac We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. At first glance, Lovesac's ROE doesn't look very promising. Next, when compared to the average industry ROE of 15%, the company's ROE leaves us feeling even less enthusiastic. As a result, Lovesac reported a very low income growth of 4.0% over the past five years. As a next step, we compared Lovesac's net income growth with the industry and were disappointed to see that the company's growth is lower than the industry average growth of 11% in the same period. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is LOVE fairly valued? This infographic on the company's intrinsic value has everything you need to know. Lovesac doesn't pay any regular dividends, meaning that potentially all of its profits are being reinvested in the business. However, this doesn't explain the low earnings growth the company has seen. So there could be some other explanation in that regard. For instance, the company's business may be deteriorating. Overall, we have mixed feelings about Lovesac. While the company does have a high rate of profit retention, its low rate of return is probably hampering its earnings growth. Having said that, looking at the current analyst estimates, we found that the company's earnings are expected to gain momentum. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company. — Investing narratives with Fair Values Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor Fair Value Estimated: A$22.83 · 0.1% Overvalued Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor Fair Value Estimated: €14.40 · 0.3% Overvalued Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor Fair Value Estimated: $359.72 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
